期刊文献+

非生物型人工肝治疗肝衰竭病人列线图预后模型的构建 被引量:1

A nomogram prognostic model for liver failure patients treated with non-bioartificial liver support system
暂未订购
导出
摘要 目的基于多因素Cox回归分析探讨行非生物型人工肝治疗肝衰竭病人的预后影响因素并构建列线图预后模型,以指导临床决策。方法回顾性收集2014年1月至2022年12月于山西医科大学第一医院感染科收治的275例行非生物型人工肝治疗肝衰竭病人的临床资料,依据病人3个月的病情随访结局分为生存组(177例)和不良结局组(98例),对观察指标进行单因素与多因素Cox回归分析,基于特征变量绘制列线图预测模型并评价模型。利用X-tile 3.6.1软件将列线图风险得分进行分组进一步探讨其临床价值。结果生存组的年龄、血清总胆红素[(364.98±151.22)μmol/L比(434.69±144.45)μmol/L]、凝血酶原时间[25.00(20.80,31.45)s比29.58(23.95,44.33)s]、国际标准化比值[2.17(1.91,2.82)比2.85(2.17,3.91)]低于不良结局组(P<0.05);凝血酶原活动度[33.12(24.10,39.20)%比25.73(19.40,33.78)%]、动态MELD评分(终末期肝病预后模型)高于不良结局组(P<0.05);生存组的病因[肝炎病毒58(32.8)%,药物性48(27.1)%,酒精性33(18.6)%及其他38(21.5)%]与不良结局组[40(40.8)%,12(12.2)%,11(11.2)%及35(35.7)%]相比差异有统计学意义(P<0.05)。多因素Cox回归分析显示,病因-药物性及酒精性、年龄、血清总胆红素、凝血酶原时间、凝血酶原时间活动度、国际标准化比值及动态MELD评分为非生物型人工肝治疗肝衰竭病人预后的独立影响因素,基于上述指标构建列线图模型;该模型的一致性指数及AUC分别为0.75、0.78,校正曲线及决策分析曲线提示该模型预测性能良好,低风险病人的生存率明显优于中、高风险组(P<0.001)。结论基于病因-药物性及酒精性、年龄、血清总胆红素、凝血酶原时间、凝血酶原时间活动度、国际标准化比值及动态MELD评分构建的列线图预后模型对于行非生物型人工肝治疗肝衰竭病人的临床决策有较高指导意义。 Objective To investigate the prognostic factors and construct a nomogram prognostic model based on multifactorial Cox regression analysis in liver failure patients treated with non-bioartificial liver support system to guide clinical decision-making.Methods Clinical data of 275 liver failure patients treated with non-bioartificial liver support system in the Department of Infection,First Hospital of Shanxi Medical University from January 2014 to December 2022 were retrospectively collected,and patients were assigned into survival group(177 cases)and poor prognosis group(98 cases)based on their 3-month follow-up outcomes.The observed indicators were analyzed sequentially by univariate and multifactor Cox regression analysis,and the nomogram model was constructed based on the characteristic variables,and then the model was evaluated.Next,the nomogram risk scores were grouped using X-tile 3.6.1 software to further explore their clinical value.Results Age,serum total bilirubin[(364.98±151.22)mmol/L vs.(434.69±144.45)mmol/L],plasminogen time[25.00(20.80,31.45)s vs.29.58(23.95,44.33)s],and international normalized ratio[2.17(1.91,2.82)vs.2.85(2.17,3.91)]in survival group were lower than those in the poor prognosis group(P<0.05);and plasminogen activity[33.12(24.10,39.20)%vs.25.73(19.40,33.78)%],and ambulatory MELD score in survival group were higher than those in the poor outcome group(P<0.05);the etiology of the disease in the survivor group[hepatitis viruses 58(32.8)%,pharmacologic 48(27.1)%,alcoholic 33(18.6)%,and other 38(21.5)%]was higher than those in the poor prognosis group[40(40.8)%,12(12.2)%,11(11.2)%and 35(35.7)%],and the difference was statistically significant(P<0.05).Multi-factor Cox regression analysis showed that etiology-drug and alcohol,age,total serum bilirubin,prothrombin time,prothrombin time activity,international normalized ratio and dynamic MELD score were independent factors affecting the prognosis of patients with liver failure treated with abiotic artificial liver,and a nomogram model was constructed based on these indicators.The consistency index and AUC of the model were 0.75 and 0.78,respectively,and the calibration curve and decision analysis curve suggested that the model had good predictive performance,and in addition,the survival rate of low-risk patients was significantly better than that of the medium-and high-risk groups(P<0.001).Conclusion The nomogram prognostic model based on etiology-drug and alcohol,age,total serum bilirubin,prothrombin time,prothrombin time activity,international normalized ratio and dynamic MELD score has high clinical guideline significance in liver failure patients treated with non-bioartificial liver support system.
作者 史诗 王一帆 杨艳芬 刘元丽 余红梅 邓春青 SHI Shi;WANG Yifan;YANG Yanfen;LIU Yuanli;YU Hongmei;DENG Chunqing(School of Public Health,Shanxi Medical University,Taiyuan,Shanxi 030001,China;Department of Infection,The First Hospital of Shanxi Medical University,Taiyuan,Shanxi 030001,China)
出处 《安徽医药》 2025年第4期798-804,共7页 Anhui Medical and Pharmaceutical Journal
基金 北京肝胆相照基金会“2022年度人工肝专项基金”项目(iGandanF-1082022-RGG005)
关键词 非生物型人工肝 肝衰竭 多因素Cox回归 列线图模型 预后 Non-bioartificial liver support system Liver failure Multifactorial Cox regression Nomogram model Prognosis
  • 相关文献

参考文献11

二级参考文献84

  • 1赵婧婷,王莉,余洪烈.双重血浆吸附联合血浆置换对肝衰竭患者细胞因子表达及肝功能的影响[J].现代医学,2020,48(10):1264-1267. 被引量:2
  • 2Ruolin Dong,Bo Wan,Su Lin,Mingfang Wang,Jiaofeng Huang,Yinlian WU,Yilong WU,Nanwen Zhang,Yueyong Zhu.Procalcitonin and Liver Disease: A Literature Review[J].Journal of Clinical and Translational Hepatology,2019,7(1):51-55. 被引量:10
  • 3Lan-JuanLi QianYang Jian-RongHuang Xiao-WeiXu Yue-MeiChen Su-ZhenFu.Effect of artificial liver support system on patients with severe vira hepatitis:A study of four hundred cases[J].World Journal of Gastroenterology,2004,10(20):2984-2988. 被引量:80
  • 4叶卫江,李兰娟,俞海燕,张新萍,田静,白明辉.血浆置换联合血液滤过治疗慢性乙型重型肝炎的临床研究[J].中华肝脏病杂志,2005,13(5):370-373. 被引量:53
  • 5童娅玲,黄建荣,陈月美.选择性血浆置换治疗慢性重型肝炎临床疗效观察[J].中华传染病杂志,2006,24(2):124-126. 被引量:18
  • 6Peter Ferenci,Alan Lockwood,Kevin Mullen,Ralph Tarter,Karin Weissenborn,Andres T. Blei.Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998[J].Hepatology.2002(3)
  • 7Shiv Kumar Sarin,Ashish Kumar,John A. Almeida,Yogesh Kumar Chawla,Sheung Tat Fan,Hitendra Garg,H. Janaka Silva,Saeed Sadiq Hamid,Rajiv Jalan,Piyawat Komolmit,George K. Lau,Qing Liu,Kaushal Madan,Rosmawati Mohamed,Qin Ning,Salimur Rahman,Archana Rastogi,Stephen M. Riordan,Puja Sakhuja,Didier Samuel,Samir Shah,Barjesh Chander Sharma,Praveen Sharma,Yasuhiro Takikawa,Babu Ram Thapa,Chun-Tao Wai,Man-Fung Yuen.Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)[J].Hepatology International.2009(1)
  • 8Russell Wiesner,Erick Edwards,Richard Freeman,Ann Harper,Ray Kim,Patrick Kamath,Walter Kremers,John Lake,Todd Howard,Robert M. Merion,Robert A. Wolfe,Ruud Krom.Model for end-stage liver disease (MELD) and allocation of donor livers[J].Gastroenterology.2003(1)
  • 9Zhen Zheng,Xu Li,Zhiliang Li,Xiaochun Ma.Artificial and bioartificial liver support systems for acute and acute-on-chronichepatic failure: A meta-analysis and meta-regression[J]. Experimental and Therapeutic Medicine . 2013 (4)
  • 10Kama A. Wlodzimirow,Saeid Eslami,Ameen Abu‐Hanna,Martin Nieuwoudt,Robert A. F. M. Chamuleau.A systematic review on prognostic indicators of acute on chronic liver failure and their predictive value for mortality[J]. Liver Int . 2012 (1)

共引文献818

同被引文献36

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部